These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2836303)

  • 1. Influence of H-2K transfection on susceptibility of fibrosarcoma tumor cells to natural killer (NK) cells.
    Gopas J; Segal S; Hammerling G; Bar-Eli M; Rager-Zisman B
    Immunol Lett; 1988 Mar; 17(3):261-5. PubMed ID: 2836303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to NK and metastatic potential of fibrosarcoma cells is associated with products encoded by the H-2D region.
    Rager-Zisman B; Aboud M; Gopas J; Har-Vardi I; Hämmerling GJ; Segal S
    Semin Cancer Biol; 1991 Oct; 2(5):329-36. PubMed ID: 1773048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NK sensitivity, H-2 expression and metastatic potential: analysis of H-2Dk gene transfected fibrosarcoma cells.
    Gopas J; Rager-Zisman B; Har-Vardi I; Hammerling GJ; Bar-Eli M; Segal S
    J Immunogenet; 1989; 16(4-5):305-13. PubMed ID: 2639905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NK sensitivity, H-2, c-K-ras proto-oncogene expression and metastases: analysis of the metastatic potential of H-2 gene transfected fibrosarcoma cells.
    Rager-Zisman B; Gopas J; Bar-Eli M; Har-Vardi I; Hammerling GJ; Segal S
    Adv Exp Med Biol; 1988; 233():151-60. PubMed ID: 3066149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunobiology of metastatic processes: analysis of NK sensitivity and the metastatic potential of H-2 gene transfected fibrosarcoma cells.
    Gopas J; Rager-Zisman B; Bar-Eli M; Har-Vardi I; Hammerling GJ; Segal S
    Nat Immun Cell Growth Regul; 1988; 7(3):155-62. PubMed ID: 2845261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergent effects of H-2K and H-2D genes on sensitivity of BL6 melanoma cells to NK cells or TNF-mediated cytotoxicity.
    Kim M; Duty L; Herberman R; Gorelik E
    Cell Immunol; 1994 May; 155(2):358-71. PubMed ID: 8181071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H-2Kb antigen expression has no effect on natural killer susceptibility and tumorigenicity of a murine hepatoma.
    Nishimura MI; Stroynowski I; Hood L; Ostrand-Rosenberg S
    J Immunol; 1988 Dec; 141(12):4403-9. PubMed ID: 3264312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased sensitivity to MHC-nonrestricted lysis of BL6 melanoma cells by transfection with class I H-2Kb gene.
    Gorelik E; Jay G; Kwiatkowski B; Herberman RB
    J Immunol; 1990 Sep; 145(5):1621-32. PubMed ID: 2384672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconstitution of H-2 class I expression by gene transfection decreases susceptibility to natural killer cells of an EL4 class I loss variant.
    Sturmhöfel K; Hämmerling GJ
    Eur J Immunol; 1990 Jan; 20(1):171-7. PubMed ID: 2106441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NK-mediated elimination of mutant lymphocytes that have lost expression of MHC class I molecules.
    Kusunoki Y; Kyoizumi S; Honma M; Kubo Y; Ohnishi H; Hayashi T; Seyama T
    J Immunol; 2000 Oct; 165(7):3555-63. PubMed ID: 11034355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H-2K double transfectants of tumor cells as antimetastatic cellular vaccines in heterozygous recipients. Implications for the T cell repertoire.
    Mandelboim O; Feldman M; Eisenbach L
    J Immunol; 1992 Jun; 148(11):3666-73. PubMed ID: 1588053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association in the expression of Kirsten-ras oncogene and the major histocompatibility complex class I antigens in fibrosarcoma tumor cell variants exhibiting different metastatic capabilities.
    Alon Y; Hammerling GJ; Segal S; Bar-Eli M
    Cancer Res; 1987 May; 47(10):2553-7. PubMed ID: 3552201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for indirect involvement of the H-2Kb gene in the regulation of natural killer sensitivity of BL6 melanoma cells.
    Kim M; Herberman R; Gorelik E
    Nat Immun; 1994; 13(1):1-14. PubMed ID: 8111189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells.
    Karlhofer FM; Ribaudo RK; Yokoyama WM
    Nature; 1992 Jul; 358(6381):66-70. PubMed ID: 1614533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
    Gorelik E; Gunji Y; Herberman RB
    J Immunol; 1988 Mar; 140(6):2096-102. PubMed ID: 3126240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein bound polysaccharide PSK abrogates more efficiently experimental metastases derived from H-2 negative than from H-2 positive fibrosarcoma tumor clones.
    Algarra I; Collado A; Garrido F
    J Exp Clin Cancer Res; 1997 Dec; 16(4):373-80. PubMed ID: 9505208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastasis of mouse T lymphoma cells is controlled by the level of major histocompatibility complex class I H-2Dk antigens.
    VandenDriessche T; Geldhof A; Bakkus M; Toussaint-Demylle D; Brijs L; Thielemans K; Verschueren H; De Baetselier P
    Int J Cancer; 1994 Jul; 58(2):217-25. PubMed ID: 8026885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NK sensitivity and lung clearance of MHC-class-I-deficient cells within a heterogeneous fibrosarcoma.
    Algarra I; Ohlén C; Perez M; Ljunggren HG; Klein G; Garrido F; Kärre K
    Int J Cancer; 1989 Oct; 44(4):675-80. PubMed ID: 2507453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of MHC-class-I antigens in clones of methylcholanthrene-induced tumors. Implications for local growth and metastasis.
    Algarra I; Gaforio JJ; Garrido A; Mialdea MJ; Pérez M; Garrido F
    Int J Cancer Suppl; 1991; 6():73-81. PubMed ID: 2066185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H-2 allele-specific protection from NK cell lysis in vitro for lymphoblasts but not tumor targets. Protection mediated by alpha 1/alpha 2 domains.
    Sentman CL; Olsson MY; Salcedo M; Höglund P; Lendahl U; Käre K
    J Immunol; 1994 Dec; 153(12):5482-90. PubMed ID: 7989750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.